Use of anti tumor necrosis factor-alpha monoclonal antibody for ulcerative jejunoileitis

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 18, Issue 36

This Article

Citation of this article

Corresponding Author of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Number of Hits and Downloads for This Article

All Articles published online

Item

Count

PDF

359

HTML

3058

Figures (1-4)

195

Sum=3612

Sep 28, 2012 (publication date) through Nov 4, 2024

Times Cited of This Article

Journal Information of This Article

Publication Name

World Journal of Gastroenterology

ISSN

1007-9327

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Case Report

World J Gastroenterol. Sep 28, 2012; 18(36): 5135-5137
Published online Sep 28, 2012. doi: 10.3748/wjg.v18.i36.5135

Full Size Figure Download Figure

Figure 4 Complete improvement on endoscopic findings after infliximab therapy. A: Jejunojejunostomy; B: Distal jejunum.

Citation: Seven G, Assaad A, Biehl T, Kozarek RA. Use of anti tumor necrosis factor-alpha monoclonal antibody for ulcerative jejunoileitis. World J Gastroenterol 2012; 18(36): 5135-5137
URL: https://www.wjgnet.com/1007-9327/full/v18/i36/5135.htm
DOI: https://dx.doi.org/10.3748/wjg.v18.i36.5135